Drug news
AG200-15 (Agile Therapeutics) contraceptive patch filed at FDA
Agile Therapeutics has made a new drug application for its once-weekly, low-dose contraceptive patch, AG200-15,(ethinyl estradiol plus levonorgestrel) and the application was accepted for a standard 10-month review by the FDA. The FDA may make a decision by the first quarter of next year.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins